Skip to main content
. 2019 Dec 18;51(6):989–995. [Article in Chinese] doi: 10.19723/j.issn.1671-167X.2019.06.002

3.

IMNM不同抗体组间肌肉病理特征比较

Comparisons of pathological features of different serological subgroups of IMNM

Features IMNM (n=104) Anti-SRP (n=47) Anti-HMGCR (n=23) MSAs negative (n=34) P
MHC-Ⅰ, major histocompatibility complex class Ⅰ; MAC, membrane attack complex; other abbreviations as in Table 1. Date are shown as n(%). *P<0.017, between anti-SRP /anti-HMGCR group and MSAs negative group; # P<0.017, between anti-SRP and MSAs negative group; △ P<0.017, between anti-HMGCR and MSAs group.
Muscle fibre
Necrosis 98 (94.2) 43 (91.5) 21 (91.3) 34 (100.0) 0.213
Regeneration 70 (67.3) 33 (70.2) 11 (47.8) 26 (76.5) 0.066
Phagocytosis 68 (65.4) 27 (57.4) 14 (60.9) 27 (79.4) 0.107
Connective tissue proliferation 36 (34.6) 17 (36.2) 8 (34.8) 11 (32.4) 0.938
MHC-Ⅰ expression on sarcolemma 82 (78.8) 35 (74.5) 17(73.9) 30 (88.2) 0.263
Partial expression 56 (53.8) 24 (51.1) 11 (47.8) 21 (61.8) 0.512
Diffuse expression 26 (25.0) 11 (23.4) 6 (26.1) 9 (26.5) 0.953
Inflammation infiltration
CD4+T cell 85 (81.7) 35 (74.5) 18 (78.3) 32 (94.1) 0.045
Endomysial 71 (68.3) 27 (57.4) 14 (60.9) 30 (88.2) 0.009*
Perivascular 30 (28.8) 17 (36.2) 6 (26.1) 7 (20.6) 0.295
CD8+T cell 57 (54.8) 21 (44.7) 11 (47.8) 25 (73.5) 0.027#
Endomysial 48 (46.2) 17 (36.2) 8 (34.8) 23 (67.6) 0.009*
Perivascular 17 (16.3) 8 (17.0) 4 (17.4) 5 (14.7) 0.951
CD20+B cell 7 (6.7) 2 (4.3) 1 (4.3) 4 (11.8) 0.361
Endomysial 4 (3.8) 1 (2.1) 0 3 (8.8) 0.168
Perivascular 3 (2.9) 1(2.1) 1 (4.3) 1 (2.9) 0.124
CD68+ macrophage 79/99 (79.8) 35/44 (79.5) 11/21 (52.4) 32 (94.1) 0.002
Endomysial 65/99 (65.7) 26/44 (59.1) 8/21 (38.1) 31 (91.2) <0.001*
Perivascular 24/99 (24.2) 18/44 (40.9) 3/21 (15.0) 3 (8.8) 0.003#
MAC 77/99 (77.8) 34/44 (77.3) 11/21 (52.4) 32 (94.1) 0.001
Sarcolemma 55/99 (55.6) 20/44 (45.5) 9/21 (42.9) 26 (76.5) 0.015*
Sarcoplasm 18/99 (18.2) 8/44 (18.2) 3/21 (14.3) 7 (20.6) 0.841
Capillaries 31/99 (31.3) 19/44 (43.2) 4/21 (19.0) 8 (23.5) 0.070